NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Peregrine Pharmaceuticals Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Avid Bioservices Becomes U.S. West Coast Partner of Boehringer Ingelheim's Global Production Alliance Network for Biologic Contract Manufacturing Services
2009 OCT 5 ... scale production needs." Avid Bioservices is a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM). Keywords: Biologics, ...
Subject: Biologics
Price: $3.00
*
Avid Bioservices Expands Executive Team as it Prepares for Continued Growth
2009 SEP 7 ... Prior to joining Agilent, Mr. Eso served as director of corporate development at Peregrine Pharmaceuticals, the parent company of Avid. Previously, he served as manager of ... Avid Bioservices, Inc., a leading provider of cGMP contract manufacturing of biologics and other key services, ...
Subject: Pharmaceuticals
Price: $3.00
*
Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrine's Cotara(R) for Treatment of Brain Cancer
2009 SEP 14 ... Pharmaceutical Business, Pharmaceutical Company, Surgery, Therapy, Treatment, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Glioblastoma
Price: $3.00
*
Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
2009 JUL 27 ... at our conference." Some of the companies presenting on July 30th include Peregrine Pharmaceuticals (NASDAQ:PPHM), Cytori Therapeutics (NASDAQ:CYTX), NovaBay ... Jesup & Lamont, Inc., (AMEX: JLI), a full-service boutique brokerage and investment banking firm serving ...
Subject: Pharmaceuticals
Price: $3.00
*
NIAID Awards New Grant to Expand Studies of Peregrine's Anti-PS Antibodies to Treat Viral Hemorrhagic Fevers
2009 SEP 7 ... Pre-Trials Research, Therapies, Therapy, Treatment, Tropical Disease, Virology, Peregrine Pharmaceuticals Inc. This article was prepared by AIDS Weekly editors from staff and other ...
Subject: Hemorrhagic Fever
Price: $3.00
*
Peregrine Pharmaceuticals Adds Noted Oncologist Dr. Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs
2009 SEP 14 ... Public Health, Pulmonology, Respiratory Infection, Taxol, Therapy, Treatment, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Cancer
Price: $3.00
*
Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
2009 NOV 2 ... Company, Pharmaceuticals, Therapy, Treatment, U.S. Food and Drug Administration, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Monoclonal Antibodies
Price: $3.00
*
Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
2009 NOV 16 ... Company, Phosphatidylserine, Rabies, Therapy, Treatment, Tropical Disease, Virology, Peregrine Pharmaceuticals Inc. This article was prepared by AIDS Weekly editors from staff and other ...
Subject: Virology
Price: $3.00
*
Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
2009 OCT 19 ... Therapy, Treatment, Tropical Disease, Viral Research, Virology, Visceral Leishmaniasis, Peregrine Pharmaceuticals Inc. This article was prepared by Anti-Infectives Week editors from staff and ...
Subject: Cancer Vaccines
Price: $3.00
*
Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
2009 AUG 3 ... Pre-Trials Research, Therapy, Treatment, VEGF, Vascular Endothelial Growth Factor, Peregrine Pharmaceuticals Inc.; Affitech A/S. This article was prepared by Biotech Business Week editors ...
Subject: Vascular Endothelial Growth Factor
Price: $3.00
*
Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements
2009 NOV 16 ... Pharmaceuticals, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Pharmaceuticals
Price: $3.00
*
Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
2009 NOV 2 ... Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, Women's Health, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Breast Cancer
Price: $3.00
*
Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
2009 SEP 21 ... Pharmaceutical Company, Pulmonology, Respiratory Infection, Treatment, Women's Health, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Breast Cancer
Price: $3.00
*
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
2009 JUL 27 ... Pulmonology, Respiratory Infection, Tropical Disease, Virology, Women's Health, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Cancer
Price: $3.00
*
Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2010
2009 SEP 14 ... Business, Pharmaceutical Company, Tropical Disease, Virology, Bavituximab, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Monoclonal Antibodies
Price: $3.00
*
Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial
2009 OCT 19 ... Pharmaceuticals, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Lung Cancer
Price: $3.00
*
Peregrine Pharmaceuticals to Present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference
2009 AUG 3 ... Keywords: Peregrine Pharmaceuticals, Pharmaceutical Business, Pharmaceutical Company, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Pharmaceuticals
Price: $3.00
*
Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
2009 SEP 14 ... Keywords: Peregrine Pharmaceuticals, Pharmaceutical Business, Pharmaceutical Company, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Pharmaceuticals
Price: $3.00
*
Peregrine Pharmaceuticals to Report First Quarter FY 2010 Financial Results
2009 SEP 7 ... Keywords: Peregrine Pharmaceuticals, Pharmaceutical Business, Pharmaceutical Company, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Pharmaceuticals
Price: $3.00
*
Peregrine Pharmaceuticals to Report Fiscal Year 2009 Financial Results
2009 JUL 13 ... Keywords: Peregrine Pharmaceuticals, Pharmaceutical Business, Pharmaceutical Company, Peregrine Pharmaceuticals Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Pharmaceuticals
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login